Evaluation of intralipid effect on pregnancy outcomes in women with recurrent implantation failure: A retrospective cohort study

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 19

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJRM-24-6_004

تاریخ نمایه سازی: 18 مهر 1405

چکیده مقاله:

Background: Recurrent implantation failure remains a challenge in assisted reproduction. Intralipid has been proposed as an immunomodulatory intervention to improve outcomes, although evidence remains inconsistent. Objective: This study aimed to evaluate the effect of intralipid on pregnancy outcomes in women with a history of at least ۲ failed embryo transfer cycles. Materials and Methods: In this retrospective cohort study, data of ۲۷۰ women with ≥ ۲ failed embryo transfer cycles, who underwent a subsequent frozen embryo transfer (FET) at Avicenna Fertility Center, Tehran, Iran, from March ۲۰۲۱-۲۰۲۲ were extracted from medical records. Participants were allocated to the intralipid group (n = ۱۳۲), receiving ۱۰۰ mL intravenous intralipid ۲۰% ۱ wk before FET, if beta-human chorionic gonadotropin was positive, the same dose was given every ۴ wk until the end of the first trimester, or to the control group (n = ۱۳۸), undergoing routine FET treatments. Outcomes included biochemical, clinical, and ongoing pregnancy, abortion, and live birth. Results: Biochemical pregnancy rate was significantly higher in the intralipid group compared with controls (۵۱.۵% vs. ۳۷.۷%, p = ۰.۰۲۲). Clinical pregnancy (۴۳.۲% vs. ۳۶.۲%), ongoing pregnancy (۲۸.۸% vs. ۱۸.۸%), and live birth (۲۵.۸% vs. ۱۷.۴%) also favored the intralipid group, although these differences did not reach statistical significance (p > ۰.۰۵). Abortion rates were comparable between groups (۲۵.۸% vs. ۲۱.۰%, p = ۰.۳۵۷). Conclusion: Intralipid may improve biochemical pregnancy rates and shows a non-significant positive trend in other pregnancy outcomes in recurrent implantation failure cases, warranting confirmation in larger randomized controlled trials.

نویسندگان

Atoosa Karimi

Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Aniseh Dadgar

Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Haniyeh Saffari

Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Nazanin Vahedi

Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Sasan Saket

Department of Pediatric Neurology, School of Medicine, Mofid Children's Hospital, Iranian Child Neurology Center of Excellence (ICNCE), Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Soheila Arefi

Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Vander Borght M, Wyns C. Fertility and infertility: Definition and ...
  • Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, ...
  • Bashiri A, Halper KI, Orvieto R. Recurrent implantation failure-update overview ...
  • Lédée N, Vasseur C, Petitbarat M, Chevrier L, Vezmar K, ...
  • Kumar P, Marron K, Harrity C. Intralipid therapy and adverse ...
  • Coulam CB. Intralipid treatment for women with reproductive failures. Am ...
  • Rimmer MP, Black N, Keay S, Quenby S, Al Wattar ...
  • Kandi SK, Shareef OO, Obeid A, Abushama M, Ahmed B, ...
  • Al-AlZebeidi J, Lary S, Al-Jaroudi D. The effect of fat ...
  • Hirshfeld-Cytron JE, Kukora S, Lazzarone M, Cohen D, Kim YS, ...
  • Foyle KL, Sharkey DJ, Moldenhauer LM, Green ES, Wilson JJ, ...
  • Habibi S, Ramezanali F, Mostafaei P, Amirchaghmaghi E. [Recurrent implantation ...
  • Anya OC, Ajayi ER, Solanke HR, Ohanaka AI, Ubana KD. ...
  • Plaçais L, Kolanska K, Kraiem YB, Cohen J, Suner L, ...
  • Peivandi S, Mortazavi L, Gordani N, Zamaniyan M, Asgarian-Omran H, ...
  • Marchand GJ, Masoud AT, Ulibarri H, Arroyo A, Coriell C, ...
  • Han EJ, Lee HN, Kim MK, Lyu SW, Lee WS. ...
  • ESHRE Working Group on Recurrent Implantation Failure, Cimadomo D, de ...
  • Ehrlich R, Hull ML, Walkley J, Sacks G. Intralipid immunotherapy ...
  • Ma J, Gao W, Li D. Recurrent implantation failure: A ...
  • نمایش کامل مراجع